Improving Screening for Barrett’s Esophagus Could Contribute to Earlier Esophageal Cancer Identification
source: pixabay.com

Improving Screening for Barrett’s Esophagus Could Contribute to Earlier Esophageal Cancer Identification

Barrett's esophagus is a condition in which the esophagus, or the tube that connects the mouth to the stomach, becomes damaged, typically due to long-term exposure to stomach acid; this…

Continue Reading Improving Screening for Barrett’s Esophagus Could Contribute to Earlier Esophageal Cancer Identification
He Survived Acute Lymphoblastic Leukemia. Now He’s Pursuing Medicine to Help Kids Like Himself.
source: shutterstock.com

He Survived Acute Lymphoblastic Leukemia. Now He’s Pursuing Medicine to Help Kids Like Himself.

  When he thinks about his ideal career, Jaziel Olmeda imagines being in a sparkling clean, white hospital ward. His goal: to help children going through pediatric cancer diagnoses. To…

Continue Reading He Survived Acute Lymphoblastic Leukemia. Now He’s Pursuing Medicine to Help Kids Like Himself.
Updated Phase 2 Trial Data Looks Promising for Experimental Alpha-1 Antitrypsin Deficiency Therapy
source: shutterstock.com

Updated Phase 2 Trial Data Looks Promising for Experimental Alpha-1 Antitrypsin Deficiency Therapy

According to an a press release published on Business Wire, Arrowhead Pharmaceuticals Inc. recently presented updated phase 2 data at the 2023 European Association for the Study of the Liver…

Continue Reading Updated Phase 2 Trial Data Looks Promising for Experimental Alpha-1 Antitrypsin Deficiency Therapy
Certain Antibiotics Associated with Higher GvHD Risk Following Allo-HCT
[Source: pixabay.com]

Certain Antibiotics Associated with Higher GvHD Risk Following Allo-HCT

  Following allogeneic hematopoietic stem cell transplant (allo-HCT), which uses healthy stem cells from a donor, many doctors prescribe antibiotics to patients as a protective measure. Many individuals become neutropenic…

Continue Reading Certain Antibiotics Associated with Higher GvHD Risk Following Allo-HCT
Pembrolizumab Combo Fails to Reach Endpoint in Gastroesophageal Junction Cancer Trial
source: shutterstock.com

Pembrolizumab Combo Fails to Reach Endpoint in Gastroesophageal Junction Cancer Trial

According to a story from Healio, a phase 3 clinical trial evaluating pembrolizumab plus perioperative chemotherapy as a treatment for locally advanced and resectable gastric adenocarcinoma and gastroesophageal junction cancer…

Continue Reading Pembrolizumab Combo Fails to Reach Endpoint in Gastroesophageal Junction Cancer Trial
ICYMI: Enrollment Began in June for Hypoparathyroidism Natural History Study
mohamed_hassan / Pixabay

ICYMI: Enrollment Began in June for Hypoparathyroidism Natural History Study

How does hypoparathyroidism evolve and progress over time? Are available treatment and management strategies providing efficacious disease control? What are the long-term effects of hypoparathyroidism on overall health—and are there…

Continue Reading ICYMI: Enrollment Began in June for Hypoparathyroidism Natural History Study
Rare Community Profiles: Empathy through Art: A Mission to Raise Hypoparathyroidism Awareness
source: pixabay.com

Rare Community Profiles: Empathy through Art: A Mission to Raise Hypoparathyroidism Awareness

Rare Community Profiles     Rare Community Profiles is a new Patient Worthy article series of long-form interviews featuring various stakeholders in the rare disease community, such as patients, their…

Continue Reading Rare Community Profiles: Empathy through Art: A Mission to Raise Hypoparathyroidism Awareness